He wears leather jackets to the office, hates “me-too” drugs, and holds over 1,000 patents worldwide. With stock pressure mounting, can Regeneron’s resident maverick find his next blockbuster?
At Regeneron, George Yancopoulos is the rare scientist and executive who drives growth with discoveries instead of acquisitions.
The Source
TWSJ
Tech
It’s the Deadliest Room in the House—Especially for Seniors
TWSJ·2d ago·3 min read
Tech
It’s the Deadliest Room in the House—Especially for Seniors
TWSJ·2d ago·3 min read
Tech
It’s the Deadliest Room in the House—Especially for Seniors
TWSJ·2d ago·3 min read
Business
How 10 Billion Pounds of Lettuce Travel From Farms to Dinner Plates
TWSJ·2h ago·3 min read
Related
On this beat
Health
Novo Nordisk Seeks Injunction Against Eli Lilly in Dispute Over Weight-Loss Ads
TWSJ·10h ago·3 min read
Health
Ipsen Drug Misses Goal in Late-Stage Trial for Rare Liver Disease
TWSJ·13h ago·3 min read
Health
Ipsen Drug Misses Goal in Late-Stage Trial for Rare Liver Disease
TWSJ·13h ago·3 min read
Health
Sanofi to Drop Eczema Drug Amid Review of Pipeline Under New CEO
TWSJ·14h ago·3 min read